Skip to main content
Article
Use of phosphodiesterase type 5 inhibitors in assistive living and home care settings
Applied Nursing Research
  • Rose Iannino-Renz
  • Diana Mager, Fairfield University
Document Type
Article
Publication Date
1-1-2015
Abstract

The purpose of this descriptive study was to assess frequency of phosphodiesterase type (PDE-5) inhibitor use (sildenafil, tadalafil, ardenafil) in community settings.

Comments

Copyright 2015 Elsevier. A link to full text has been provided for authorized subscribers.

Published Citation
Iannino-Renz, Rose, and Diana Mager. "Use of phosphodiesterase type 5 inhibitors in assistive living and home care settings." Applied Nursing Research 28.3 (2015): 251-253. DOI:10.1016/j.apnr.2015.04.006
DOI
10.1016/j.apnr.2015.04.006
Citation Information
Rose Iannino-Renz and Diana Mager. "Use of phosphodiesterase type 5 inhibitors in assistive living and home care settings" Applied Nursing Research Vol. 28 Iss. 3 (2015)
Available at: http://works.bepress.com/diana_mager/11/